The Centers for Medicare & Medicaid Services just announced 15 new drugs it wants to lower the cost for including popular, ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...
The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...